Posts With Tag IoT

Discover Regeneron Pharmaceuticals' June 13, 2025, 8-K filing, detailing key corporate events and stock info essential for investors.

Explore Amgen Inc.'s latest 8-K report from May 23, 2025, detailing significant financial activities, including the issuance of 2.00% Senior Notes and stock information.

Explore Illumina, Inc.'s 8-K filing from May 21, 2025, detailing crucial, time-sensitive updates for investors.

AstraZeneca PLC completes the acquisition of EsoBiotec for up to $1 billion, enhancing its oncology portfolio with innovative cell therapies. Learn more about this transformative deal.

Discover vital insights from Vertex Pharmaceuticals' 8-K filing on May 19, 2025, detailing significant corporate events. Stay informed about VRTX stock and market changes.

Explore Vertex Pharmaceuticals Inc.'s recent 8-K filing, revealing significant corporate changes and insights for investors. Stay informed about VRTX's latest developments.

Explore Marriott International Inc.'s significant event reported in the 8-K filing on May 9, 2025. Key insights on stock performance, compliance, and corporate updates included.

Explore Marriott's latest 8-K/A filing detailing Sean Tresvant's election to the Board and his committee appointments, emphasizing tech oversight and social impact.

Explore Dexcom, Inc.'s 8-K report detailing significant events and stock performance as of May 9, 2025. Get insights on DXCM and corporate developments impacting investors.

Explore Illumina's Q1 2025 financial performance, revealing $947M revenue, $131M net income, and strategic insights post-GRAIL spin-off. Key trends and future outlook included.

Explore Gilead Sciences' 8-K filing detailing significant events on May 7, 2025. Stay informed on market implications for GILD shareholders.

Discover crucial updates from Illumina, Inc. in their 8-K report filed on May 8, 2025, impacting shareholders and stakeholders.